Leading biotechnology companies listed on ASX Australia 2024
CSL was the leading Biotechnology company listed on the Australian Securities Exchange (ASX) in Australia as of June 3, 2024, with a market cap of around 135 billion Australian dollars. CSL specializes in rare and serious diseases and influenza vaccines.